Management of venous thromboembolism in patients with primary and metastatic brain tumors.
about
Venous thromboembolic diseaseVenous thromboembolism in cancer patients: an underestimated major health problemMedical management of brain tumors and the sequelae of treatment.Through the patient's eyes: the value of a comprehensive brain tumor center.Venous thromboembolism in malignant gliomasSupportive management of patients with brain tumors.Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas.Treating venous thromboembolism in patients with cancer.Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling.Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment.A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response.Venous thromboembolism and survival in patients with high-grade glioma.Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.Anticoagulant use in cancer patients.Management of venous thromboembolism in patients with cancer.Current concepts and management of glioblastoma.Enoxaparin once daily vs. twice daily dosing for the treatment of venous thromboembolism in cancer patients: a literature summary.Risk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients.Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario.Current advances in understanding and managing secondary brain metastasis.Managing Disease and Therapy-Related Complications in Patients with Central Nervous System Tumors.Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery.Thromboembolic disease in patients with high-grade glioma.Intracranial hemorrhage during GliaSite RTS manipulation in an anticoagulated patient.Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome.Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence.A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation: comment.Successful administration of a low dose of calcium nadroparin in patients suffering from pulmonary embolism and brain metastases: a report of two cases.Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
P2860
Q24631121-F0F83624-D216-48F3-A8A2-57DB86656B1AQ26852015-BB93AA5A-2E0C-48D6-B8BE-7AF503A3AE05Q26992174-C984C7B0-73B1-4BBA-843A-A254DE8BD1DDQ30364757-EA08FF79-A71E-455A-9D71-1C257FE48D39Q30436810-F7D6FBCC-7D08-40E9-A578-F1ED761EF91DQ30444752-19C457A6-CDD6-4DFB-A84D-08752FA8F427Q33384450-6462EA90-0C6A-40EF-B02B-D6E2AE96E51FQ33400564-3ECA1449-D949-4ABE-97C1-8F04F1138221Q33959220-F6D9A30A-275F-49A0-A78F-0C914D3410DBQ34208140-BCDEB39E-EC13-4E3F-9438-1D958709E2F0Q35602183-01D69C07-5BE5-4E7B-8CD8-8B2B76ED208AQ35799978-4FD806C6-4AEA-46E3-9999-BA0DD9D54C82Q35994289-DCFF483D-1381-4C11-AE6C-800B5AF33F2AQ37831345-3E3327CC-71EB-4334-8E03-C2FA23443DFBQ37903957-4F07B43D-94CE-4EA4-AAE0-FB1789713F55Q37904921-29A7F6CD-8D52-4097-8F17-79E0A448CD1CQ37935403-1D8FABD1-717B-4EB9-A224-3A7BC01B13FEQ37960412-37206897-D8D9-401A-84A4-9093057C5551Q38066590-9184EAE5-61C6-475A-805D-BB12B2DB9FD2Q38233076-119E1FBB-ABA9-48C1-BC28-F1A51078D70BQ38542829-483E7056-6AA8-4EA7-9924-DEFD71F10ED8Q39260347-88995BD7-70CA-44B1-9C41-8DCDFCB64C93Q42407190-C48294F4-0F3F-41BC-8D08-84CDB8EC52F5Q43194289-D1A8054B-4FD2-4C81-B429-40CCA831792EQ44197966-186E4D89-321A-4777-A097-B1A98801DCCFQ47797800-3A188A11-3F99-400C-B9AB-A89D347BE3DCQ47959893-A7DB3278-0F67-4775-8A11-A945708FE4A9Q47963389-CAE69CDD-8B10-4AE6-A939-27A301915D9FQ48273783-B524A2AD-588B-4094-BDD1-2E13557CE1D4Q48377067-66F5C2D1-DDC9-4FAD-A284-62926669B9FDQ49123780-AC306E70-E41A-4C3F-9D92-6219035B7BBA
P2860
Management of venous thromboembolism in patients with primary and metastatic brain tumors.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Management of venous thromboem ...... y and metastatic brain tumors.
@ast
Management of venous thromboem ...... y and metastatic brain tumors.
@en
type
label
Management of venous thromboem ...... y and metastatic brain tumors.
@ast
Management of venous thromboem ...... y and metastatic brain tumors.
@en
prefLabel
Management of venous thromboem ...... y and metastatic brain tumors.
@ast
Management of venous thromboem ...... y and metastatic brain tumors.
@en
P356
P1476
Management of venous thromboem ...... y and metastatic brain tumors.
@en
P2093
Michael B Streiff
Stuart A Grossman
P304
P356
10.1200/JCO.2005.04.6656
P407
P577
2006-03-01T00:00:00Z